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ABSTRACT
Objective: To identify risk factors for the use of hormonal contraceptives in users of these methods. Method: 
Descriptive study of a quantitative approach carried out between January and April 2016 in Redenção, Ceará, 
Brazil. The women were invited to respond to a structured form. The ethical principles of this research have 
been secured. The data were tabulated and analyzed by descriptive statistics through SPSS 20.0. Results: 
100 women participated. Mean age = 26.91 years. 75% had performed Reproductive Planning. The most 
prevalent risk factor was migraine (59%). In the family history, the most frequently reported disease was 
systemic arterial hypertension (75%). Conclusions: Previously related diseases of patients with high ages 
are increasingly present in young women, who need more assistance in reproductive planning, focusing on 
anamnesis and general physical examination, responsible for revealing significant findings for the eligibility 
of contraceptive methods, aiming to the reduction of health risks.
Descriptors: Contraception; Primary Care Nursing; Risk Factors; Women’s Health.
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RESUMO
Objetivo: Identificar fatores de risco para uso de anticoncepcionais 
hormonais em usuárias desses métodos. Método: Estudo descritivo 
de abordagem quantitativa realizado entre janeiro e abril de 2016 em 
Redenção, Ceará, Brasil. As mulheres foram convidadas a responder 
um formulário estruturado. Os princípios éticos desta pesquisa foram 
assegurados. Os dados foram tabelados e analisados por estatística 
descritiva através do SPSS 20.0. Resultados: Participaram 100 mulheres. 
Média de idade = 26,91 anos. 75% haviam realizado Planejamento 
Reprodutivo. O fator de risco mais prevalente foi a enxaqueca (59%). 
No histórico familiar, a doença mais relatada foi Hipertensão Arterial 
Sistêmica (75%). Conclusão: Doenças antes relacionadas a pacientes 
com idades elevadas estão cada vez mais presentes em mulheres jovens, 
que necessitam de maior assistência no planejamento reprodutivo, com 
foco na anamnese e exame físico geral, responsáveis por revelar achados 
significantes para a elegibilidade de métodos contraceptivos, visando a 
redução de riscos à saúde. 
Descritores: Anticoncepção; Enfermagem de Atenção Primária; Fatores 
de Risco; Saúde da Mulher.
RESUMÉN
Objetivo: Identificar factores de riesgo para el uso de anticonceptivos 
hormonales en las usuarias de estos métodos. Método: Estudio 
descriptivo de abordaje cuantitativo realizado entre enero y abril de 2016 
en Redención, Ceará, Brasil. Las mujeres fueron invitadas a responder a 
un formulario estructurado. Los principios éticos de esta investigación 
fueron asegurados. Los datos fueron tabulados y analizados por 
estadística descriptiva a través del SPSS 20.0. Resultados: Participaron 
100 mujeres. Media de edad = 26,91 años. El 75% habían realizado 
Planificación Reproductiva. El factor de riesgo más prevalente fue la 
migraña (59%). En el historial familiar, la enfermedad más relatada fue 
Hipertensión Arterial Sistémica (75%). Conclusión: Las enfermedades 
antes relacionadas con los pacientes con edades elevadas están cada vez 
más presentes en mujeres jóvenes, que necesitan una mayor asistencia 
en la planificación reproductiva, con foco en la anamnesis y examen 
físico general, responsables de revelar hallazgos significantes para la 
elegibilidad de métodos anticonceptivos, visando la reducción de los 
riesgos para la salud.
Descriptores: Anticoncepción; Enfermería de Atención Primaria; 
Factores de Riesgo Salud de la Mujer. 
INTRODUCTION
Hormonal contraceptives are medicines used by women 
who wish to postpone or avoid pregnancy, in addition to 
having other therapeutic effects. They are characterized 
as reversible methods and are available in the form of 
pills, injectables, adhesives, etc. Moreover, they present 
high effectiveness rates, which favors their use.1 In Brazil, 
progestin-only hormonal contraceptives, as well as 
combined estrogen and progestin ones, are most commonly 
used and indicated in the form of pills or injectables.2 
It is estimated that more than 60% of Brazilians use oral 
contraceptive methods to prevent pregnancy.3 
Such methods may have health risks, especially if 
long-term risk factors, such as cardiovascular disease 
(CVD), deep-vein thrombosis (DVT)1 and breast cancer 
are present.4 Given this, the correct prescription of these 
drugs is essential to prevent serious side effects on women. 
Reproductive Planning (RP) is important to evaluate 
these risk factors. It is the most indicated and adequate 
method according to the patient’s health condition, 
reducing risks.1
Nevertheless, because they are easily accessible 
methods and does not require a medical prescription 
to be commercialized, many women use them on their 
own. They do not seek medical or nursing evaluation 
before using these medications, which may cause future 
adverse effects.
Considering the aforesaid, it is necessary to investigate 
the aspects related to the use of these methods, which 
may highlight important points in RP appointments, in 
addition to providing the users’ characteristics relevant to 
determine the use or replacement of the chosen method. 
In Ceará State, Brazil, few current data were found 
in databases and epidemiological bulletins regarding 
contraception. This makes it difficult to know about this 
reality, especially in the countryside, where little research 
has been carried out. Furthermore, it is important to observe 
how RP presents itself in this social space. Its fragilities, 
which demands intervention, and its competences should 
also be observed, thus characterizing the service offered 
by Primary Health Care (PHC) for women’s health. 
This study aimed at verifying whether women using 
hormonal contraceptives presented risk factors for diseases. 
METHODS
This descriptive study with a quantitative approach was 
conducted between January and April 2016 in four Basic 
Health Units (BHUs) of a municipality in the countryside 
of Ceará State, Brazil. 
A non-probabilistic sample, composed of 100 women, 
was used. They were at BHUs at the time of data collection. 
Inclusion criteria were women using oral or injectable 
hormone contraceptives and signing the informed consent 
document. Legal guardians of patients under 18 years 
old signed this document, but the latter had to sign a 
special informed consent document designed specifically 
for them. The exclusion criterion was unreachable BHUs.
The data were collected by means of interviews 
and recorded on structured forms which included 
sociodemographic and gyneco-obstetrical variables, RP 
aspects, and personal and family risk factors associated 
with the use of hormonal contraceptive methods.
The information obtained was tabulated using 
Microsoft Excel. Descriptive statistics and frequency 
distribution were performed using the Statistical Package 
for the Social Sciences (SPSS) version 20.0. 
The study followed the guidelines of the Brazilian 
National Health Council and complied with the Resolution 
No. 466/12, which regulates research involving human 
participants.5 This research was approved by the Research 
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Ethics Committee from the Universidade da Integração 
Internacional da Lusofonia Afro-Brasileira under the 
Certificado de Apresentação para Apreciação Ética (CAAE) 
[Certificate of Presentation for Ethical Appreciation] 
No. 47775015.0.0000.55.76.
RESULTS
The average age of 25.5 years old was found (SD=6.99). 
Of the total number of women, 3% aged 18 years old and 
6% aged over 40 years old. The average study time was 12 
years (SD=2.6). This group is composed of administrative 
housekeepers (21%), students (18%), housewives 
(16%), farmers (9%), among other occupations (36%). 
The majority (51%) of women live with their partner. 
Most of the women interviewed had an income higher 
than a minimum wage and 71% of them live with two 
to four people. Of the study participants, 81% were 
Catholics and 16% were Protestants, i.e., Christian religions 
were prevalent. 
The gyneco-obstetrical data showed that 51% of the 
participants had their menarche at the age of 12 years 
old or more and 76% became sexually active between 
the ages of 13 and 18 years old. Thirty percent of the 
women reported having nulliparity, while 66% had from 
one to three previous pregnancies. Eighty-five percent of 
the women reported having no spontaneous or provoked 
abortions, while 12% reported having an abortion. 
As for the number of partners over the lifetime, 73% 
reported having between one and three partners. Over 
the last three months, 89% of the participants pointed out 
that they had a sexual partner. Furthermore, 90% of them 
said that they were tested for cervical cancer at least once. 
Of these, 57% said they were tested last year.
Table 1 presents the personal and family medical history 
of these women regarding diseases caused or exacerbated 
by the use of hormonal contraceptives.
Table 1 - Personal and family risk factors for diseases among 
users of hormonal contraceptives.
Risk factor
Personal Family*
N % N %
Migraine 59 59% 10 10%
Systemic Arterial 
Hypertension 
8 8% 75 75%
Stroke 2 2% 17 17%
Diabetes Mellitus 1 1% 52 52%
Cardiovascular 
disease
1 1% 35 35%
Breast Neoplasia 0 0 8 8%
*Most users reported more than one pathology present in their family 
medical history. Regarding the degrees of kinship, first-degree and 
second-degree family links were found.
Migraine (59%) was the disease affecting most of 
the women. This can be characterized as a pre-existing 
pathology and is associated with the use of a hormonal 
contraceptive method. Hence, it can be viewed as an adverse 
effect of hormonal contraceptive use. It should be noted that 
this was a self-reported complaint, and it is important to 
conduct a medical evaluation for the differential diagnosis 
of the disease, distinguishing it from other problems such 
as headache. 
Although rare, some participants reported having 
CVD, systemic arterial hypertension (SAH), stroke, and 
diabetes mellitus (DM), which deserve more attention 
because their association with hormonal contraceptive 
methods can threaten the women’s health.
Furthermore, the family medical histories showed a 
high incidence of these diseases. More than one pathology 
per family was found for different degrees of kinship. 
SAH, CVD, and DM lead the list of pathologies most 
present in the family medical history of the participants, 
although all they have pointed out that all the diseases 
were present. 
In addition to personal and family medical history, 
other factors contribute to the quality of life of women 
using hormonal contraceptives. The results regarding RP 
appointments reported by the users are shown in Table 2.
Table 2 - RP activities influencing the women’s quality of life.
Variable
%
Yes No Not applicable*
Have you ever had a 
reproductive planning 
appointment?
75 25 -
Did you have a general 
physical examination?
41 34 25
Did you receive guidance 
on the correct use of the 
method?
64 11 25
Did you receive guidance 
on risk factors?
35 40 25
*Number of women who reported never having had an RP appointment. 
Although hormonal contraceptive methods require 
prior medical or nursing evaluation before its use, there 
were still cases (25%) in which users did not have an 
RP appointment. This indicates that these women use 
hormonal contraceptives without any guidance. Of those 
who had RP appointments, only 41% underwent a physical 
examination. According to the women, guidance in using 
contraception correctly was provided by professionals 
during the appointment.
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DISCUSSION
The average age found was similar to that of Canada 
according to a study aimed at evaluating contraceptive 
use in this country.6 This suggests that women seek 
contraception as a means to avoid or delay pregnancy 
throughout the fertile period. From the age of 40 onward, 
hormonal contraceptive use should be restricted because 
the risk of developing diseases such as those affecting the 
circulatory system tends to increase.1
The number of years of formal education are considered 
Social Determinants of Health (SDHs) because they can 
influence the search for health care services to promote self-
care.7 Thus, professionals are responsible for investigating 
this factor, aiming at providing greater guidance to users, 
which should be carried out with accessible language and 
technologies that facilitate their understanding. 
Although there is no significant difference between 
the number of women with and without a partner, the 
fact that in both cases they choose to use a reversible 
contraceptive indicates that they seek to exercise their 
reproductive rights. 
Socioeconomic conditions are also configured as 
SDHs; therefore, the Sistema Único de Saúde (SUS) 
[Brazilian Unified Health System] provides some 
contraceptive methods for free, aiming at patients with 
lower economic status.8 This explains the popularity of 
hormonal contraceptives among Brazilians as indicated 
by the study results, representing a benefit regarding the 
user’s decision to become pregnant or not. 
Although the use of contraceptives still is a taboo in 
many religions, which consider them barriers to spreading 
life, no such reality was observed in this study. This suggests 
that women have been adhering to practices that separate 
sexuality from reproduction.9 
From the menarche onward, when a woman has a sexual 
relationship without any kind of protection, she has a 
chance to get pregnant. So, the adolescent experiencing the 
first menstruation needs guidance and care to avoid early 
pregnancy and prevent Sexually Transmitted Infections 
(STIs). Accordingly, it is understood the importance of 
RP in leading women to perform self-care and promoting 
conscious contraception from this stage onward. The use of 
condoms, whether or not associated with other forms 
of contraception, is essential.1
Additionally, early menarche is a predisposing factor 
for breast cancer. If associated with prolonged use of 
hormonal contraceptives, it can increase the chances of 
developing the disease.4 Therefore, health care actions 
toward female adolescents should be broader. Breast self-
examination practices are important, being responsible for 
detecting early changes and minimizing possible damage 
to women’s health. This should be encouraged in PHC, 
and printed material or other technologies can be used 
to raise awareness among women.10
Another risk factor for breast cancer is nulliparity.11 
The presence of these isolated or associated factors should 
be investigated by RP professionals before promoting 
hormone therapy, providing information on these risk 
factors so that women can actively participate in the 
choice of using a contraceptive method. A study of 139 
women with breast cancer showed that 10.8% of them 
were nulliparous. Although this rate is relatively low, a 
relationship is observed between the absence of protective 
factors against cancer while breastfeeding.12 
The number of sexual partners influences the choice 
of using a contraceptive method. However, this factor is 
also associated with the need to seek a barrier method 
that prevents women and couples from contracting 
STIs.1 Double protection, which is the combination of 
two methods, should be encouraged, especially by the 
nurse, who has an important role in health education for 
the empowerment of the individual.
Cervical cancer tests are responsible for the early 
detection of changes that may evolve into cervical cancer 
and for the clinical examination of the breasts, in addition 
to screening for other diseases. Because of this, it is essential 
that women have the examination every year or, depending 
on their health conditions, at greater or lesser intervals. 
The Brazilian Ministry of Health recommends that the 
oncotic cytology/cervical cancer test should be performed 
during RP appointments, including breast examination.1 
Nonetheless, it can be observed in this study that the 
opposite also occurs, since there were reports of cervical 
cancer tests or child growth and development follow-up 
being performed during RP appointments. 
These are not considered inappropriate practices; 
however, the professional must recognize the relevance 
of the RP in its entirety, with attention to the general 
physical and gynecological examination. Anamnesis 
focusing on the personal and family medical history of 
the patient, in addition to appropriate records, should 
be performed. Thus, it is highlighted the importance of 
encouraging these professionals to deliver this care through 
training, implementation of checklists and record sheets 
that contribute to the quality of appointment without 
slowness, giving it practicality. 
Migraine is a disease that can be associated with both 
genetic and acquired factors. In addition to headache, 
the most common symptom, there may be other 
manifestations such as visual and olfactory sensitivity, 
nausea, etc.13 The use of hormonal contraceptives 
constitutes a risk factor for this disease, which is one 
of the eligibility criteria used by the Ministry of Health 
during the choice of the most appropriate method for 
the patient. Moreover, the risks and benefits should be 
evaluated before the use of hormonal contraceptives by 
women with migraines.1 
A study conducted with 197 undergraduate students 
in Santa Catarina State, Brazil, highlighted migraine 
as a predominant risk factor among the participants.14 
Although in the present study there is a high rate of 
migraine, there is a need for research in health care since 
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it can often be confused with a headache. So, if migraine 
cases are confirmed, an evaluation should be performed 
to replace the contraceptive because of the greater chance 
of developing a stroke. PHC teams play an important role 
in identifying health risks to prevent this condition.15 
Six out of ten women die due to stroke worldwide.16 
Ischemic stroke affects most users of hormonal 
contraceptives and is characterized by the obstruction 
of blood vessels in certain areas of the brain, preventing 
oxygenation.17 
Combined contraceptives are the most likely to increase 
the risk of developing a stroke because they contain 
estradiol. On the other hand, this risk is decreased by 
using progestogen-only contraception as long as the 
women’s clinical and behavioral condition is respected and 
guidelines on their correct use are carried out. The reason 
is that there are still myths about this type of contraception. 
For instance, it is believed that their use is recommended 
only during lactation and they are less effective among 
women who do not breastfeed.18
SAH is a clinical condition caused by several factors and 
described as the increase and maintenance of blood pressure 
(BP) levels, which can cause several health problems.19 
A study conducted in Japan showed that prolonged use of 
hormonal contraceptives directly influences the occurrence 
of hypertensive crises, which are capable of causing sequelae 
that compromise heart muscle function.20 
In the present study, the need for intervention is 
emphasized in relation to the reported cases of patients 
with SAH using hormonal contraceptives. This is because 
the risk of developing cardiovascular complications tends 
to increase over the years.6 In other cases, carrying out 
a BP evaluation every six months is indicated, as well 
as evaluation of associated factors such as smoking, 
thromboembolic diseases, and migraine.1
CVD represents the most prevalent pathology 
worldwide. It is estimated that they have increased the 
mortality rate over four years in the Northeast Region of 
Brazil.21 Moreover, CVD is the greatest cause of hospital 
admissions in the country, especially among the elderly.22 
Although only one case of CVD was reported in this study, 
it is necessary to investigate other cases among users 
considering their family history and use of contraception. 
It should also be noted that the presence of several 
associated risk factors constitutes an important eligibility 
criterion that makes the use of hormonal contraceptives 
unfeasible.1 Given the presence of cases such as those 
presented in this study, it is essential to check also how 
the anamnesis has been performed during RP. Also, it is 
important to check whether there are records of these 
pathologies and appointments, ensuring the continuity 
of care.
DM represents a metabolic syndrome that has been 
affecting an increased number of people worldwide. 
Although it is more prevalent among men, the number 
of women in this clinical condition is also large.23 Patients 
with DM may use low-dose hormonal contraceptives after 
medical evaluation, as long as there are no associated 
risk factors, such as CVD and neuropathies.1 It should 
be emphasized that the use of injectable progestogen is 
not indicated for women with DM.23
It is known that DM causes changes in blood clotting.23 
Thus, the use of hormonal contraceptives can contribute 
to the increase of these phenomena, causing complications 
such as DVT and CVD. For this reason, it is important to 
be careful with patients who wish to use contraceptives 
even if they do not have DM, which was corroborated by 
the study results. 
When identifying the pathologies reported by the 
participants, it was noticed that diseases previously 
considered to affect the elderly population are also 
present in young women, representing an alert for the 
prevention of diseases through changes in the lifestyle 
of these patients.
Hormonal contraceptives allow the emergence of several 
adverse effects, such as increased cholesterol levels, nausea, 
weight gain, and depression. Hence, considering the initial 
clinical evaluation, the user should be followed up during 
the use of the prescribed method, especially over the first 
three months, in which it is more common to occur.1
In addition to personal risk, family risk factors can 
increase the chances of developing diseases among 
contraceptive users, especially when they occur in 
first-degree relatives. Anamnesis is essential during 
RP appointments to determine how safe hormonal 
contraceptive use will be.
A study on the risk factors associated with the use of 
hormonal contraceptives indicated that having a family 
history of breast cancer was the most reported factor by 
the participants. Having a first-degree relative with breast 
cancer represents a predisposing factor for the development 
of this disease.14 
In this study, the participants who reported having 
arterial hypertension also had DM, strokes or CVD. 
Moreover, their relatives had the same pathologies. This 
represents a warning about the importance of evaluating 
women with a family history of chronic disease for 
diagnosing any early alterations.
Physical examination is one of the main moments during 
RP, in which significant changes in the patient’s general 
condition can be identified, providing the professional with 
information to encourage his/her decision regarding the 
most suitable contraceptive method. Some points, such as 
checking BP, blood glucose, weight, and body mass index 
(BMI), heart rhythm, and breast examination may reveal 
findings related to important diseases. The Ministry of 
Health recommends that the woman’s general physical 
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examination should be performed annually, including 
cervical and breast cancer test screening.1
According to the study findings, the quality of the 
guidance provided by RP professionals was considered low 
within the BHC context. However, other studies revealed 
low rates in this aspect.24-5 Guidance is responsible for 
the formation of professional-client bonds, contributing 
to improving self-care. The professional should 
provide comprehensible information to the clients and 
erase doubts.26 
In this way, professionals should be encouraged to 
provide a more comprehensive health care-related guidance 
to women in need of RP so that they become closer to 
the health service. Moreover, these professionals should 
promote knowledge of the risks and benefits caused 
by contraceptives. 
In view of this, it is emphasized the participation of 
health care managers in training RP professionals, thus 
encouraging the execution of essential procedures aiming 
at the care for women and their adequate record. Audit 
services are important tools for making high-quality 
medical records. These services help to identify the main 
problems in medical records, aiming at excellence and 
quality of information about the patient’s health.27
This study aims to contribute to the expansion of 
the care for RP patients by raising awareness among health 
care professionals so they could take an integral look at 
the aspects that can be harmful to women’s health.
CONCLUSIONS
The identification of personal and family risk factors 
associated with the use of hormonal contraceptives is 
important for the future of the study participants, who 
may develop chronic diseases. These chronic diseases can 
cause, for example, physical and motor limitations for 
women, especially the elderly ones, which are more likely 
to contract diseases. 
Concerning the RP, it is evident the need for actions 
performed in accordance with the Brazilian Ministry of 
Health. The importance of interpersonal relationship 
(professional-patient) is also underlined, supporting the 
expansion of the guidelines offered, especially on the 
risks of hormonal contraception and the risk factors that 
need monitoring. The goal is to choose the appropriate 
contraceptive method for women. 
It is also necessary to stimulate the demand for health 
care services before using any contraceptive method 
through educational activities in BHUs or in schools 
where there are adolescents because of their high demand 
for contraception.
This study has some limitations. First, a low sample 
size was used. Secondly, the participants did not undergo 
physical examination. Therefore, further research on this 
topic should be carried out in order to complement the 
data obtained, contributing to the quality of RP.
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